CARDIAC TROPONIN I DETECTION DURING PREGNANCY FOR CARDIOVASCULAR DISEASE IDENTIFICATION AND RISK ASSESSMENT

The present invention provides systems and methods for determining and reporting the cardiac troponin I (cTnI) concentration in a sample from a pregnant woman (in the first, second, or third trimester) by determining whether the sample (cTnI) concentration is higher than a 99thpercentile cTnI concen...

Full description

Saved in:
Bibliographic Details
Main Authors SONG QUEK, Yek, SICKAN, Jaganathan, YUAN WOON, Shu, NOOR, Eliza Mohd, BESHIRI, Agim, RAVICHANDRAN, Jeganathan, SURESH, Kumar, VIGNESWARAN, Ramakrishnan, LIM, Yee Cherng
Format Patent
LanguageEnglish
French
German
Published 20.02.2019
Subjects
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
PHYSICS
TESTING
Online AccessGet full text

Cover

More Information
Summary:The present invention provides systems and methods for determining and reporting the cardiac troponin I (cTnI) concentration in a sample from a pregnant woman (in the first, second, or third trimester) by determining whether the sample (cTnI) concentration is higher than a 99thpercentile cTnI concentration from a corresponding first, second, or third trimester uncomplicated pregnancy control group, thereby determining if the pregnant woman has or is at risk of developing cardiovascular disease, such as gestational hypertension.
Bibliography:Application Number: EP20170735252